Breast Cancer Research » Breast Cancer Tumor

Williston Hopes for Cancer Breakthrough

Thu, 25 Nov 2010 00:48:58 +0000

Williston Hopes for Cancer Breakthrough
A local dentist along with several businesses and individuals are hoping to make a cancer breakthrough. They’re doing this by giving a $100,000 donation to a doctor from Seattle Washington.

Camp Bluebird

Wed, 24 Nov 2010 00:46:01 +0000

Camp Bluebird
What are some of the first thoughts that come to mind when you hear the word cancer? Do you sit back and smile as you daydream of boating, fishing, stand-up comedy, celebrations of life — and partying with Elvis Presley and Tina Turner?

Cylene To Present Advances With Industry’s Only Clinical CK2 Inhibitor, CX-4945, At EORTC-NCI-AACR

Tue, 23 Nov 2010 00:59:23 +0000

Cylene To Present Advances With Industry’s Only Clinical CK2 Inhibitor, CX-4945, At EORTC-NCI-AACR
Cylene Pharmaceuticals, Inc. will present advances in the development of their first-in-class, CK2 inhibitor CX-4945, at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and Cancer Therapeutics, to be held on November 16-19 in Berlin, Germany. CX-4945 is the first and only CK2 inhibitor to have entered clinical trials and represents an exciting new approach for the treatment for many …

Mayo Clinic Proton Beam Therapy Program: Citing Benefits to Treating Patients with Cancer, Mayo Clinic Approves …

Mon, 22 Nov 2010 00:53:23 +0000

Mayo Clinic Proton Beam Therapy Program: Citing Benefits to Treating Patients with Cancer, Mayo Clinic Approves …
PHOENIX & ROCHESTER, Minn.–(BUSINESS WIRE)–Mayo Clinic today announced plans to establish the Mayo Clinic Proton Beam Therapy Program as part of Mayo’s national three-site cancer center in Minnesota, Arizona and Florida. The new program will employ intensity modulated proton therapy — based on pencil beam scanning — which is a more precise form of proton therapy treatment that allows greater …

CEO Highlights How Chronix’s Unique Blood Tests Can Enable Early Cancer Diagnosis and Personalized Treatment at Payor …

Sun, 21 Nov 2010 00:38:30 +0000

CEO Highlights How Chronix’s Unique Blood Tests Can Enable Early Cancer Diagnosis and Personalized Treatment at Payor …
Chronix Biomedical today announced that its Chief Executive Officer, Dr. Howard Urnovitz, is presenting a session on “Improving Technology for Cancer Detection and Screening” at the Payor Oncology Management Summit, a conference for healthcare insurers and providers focusing on new developments in cancer diagnosis, treatment and prevention.